Seroprevalence of Human Herpesvirus-8 in HIV-1 Infected and Uninfected Individuals in Cameroon

By Mbondji-Wonje Christelle   Ragupathy Viswanath   Lee Sherwin   Wood Owen   Awazi Bih   Hewlett Indira K.  

Viruses, Vol. 5, Iss. 9, 2013-09 ,pp. : 2253-2259

MDPI

Access to resources Recommend Favorite

Phylodynamics of HIV-1 from a Phase-III AIDS Vaccine Trial in North America

By Prez-Losada Marcos   Jobes David V.   Sinangil Faruk   Crandall Keith A.   Posada David   Berman Phillip W.  

Molecular Biology and Evolution, Vol. 27, Iss. 2, 2010-02 ,pp. : 417-425

Oxford University Press

Access to resources Recommend Favorite

Advancing Toward HIV-1 Vaccine Efficacy through the Intersections of Immune Correlates

By Tomaras Georgia D.   Haynes Barton F.  

Vaccines, Vol. 2, Iss. 1, 2013-12 ,pp. : 15-35

MDPI

Access to resources Recommend Favorite

Challenges in the Design of a T Cell Vaccine in the Context of HIV-1 Diversity

By Tongo Marcel   Burgers Wendy A.  

Viruses, Vol. 6, Iss. 10, 2014-10 ,pp. : 3968-3990

MDPI

Access to resources Recommend Favorite

Human Leukocyte Antigen (HLA) Class I Down-Regulation by Human Immunodeficiency Virus Type 1 Negative Factor (HIV-1 Nef): What Might We Learn From Natural Sequence Variants?

By Mwimanzi Philip   Markle Tristan J.   Ueno Takamasa   Brockman Mark A.  

Viruses, Vol. 4, Iss. 9, 2012-09 ,pp. : 1711-1730

MDPI

Access to resources Recommend Favorite